Matches in SemOpenAlex for { <https://semopenalex.org/work/W2414197351> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2414197351 abstract "Background Ankylosing spondylitis (AS), a chronic rheumatic disease predominantly involving the axial skeleton, can substantially impact work productivity in employed patients, resulting in economic costs to employers and society. 1,2 Objectives To assess salary growth, an integrated measure of work performance, in employed patients with AS treated with and without anti-TNF therapy. Methods Adult employees (18 – 64 years old) with at least one diagnosis of AS (ICD-9-CM: 720.0) were identified from a large-scale US employer claims database (covering individuals from 82 self-insured Fortune 500 companies, 2003Q3-2013Q1). Patients were divided into two cohorts: the anti-TNF cohort (receiving adalimumab, etanercept, golimumab, or infliximab) and the non-anti-TNF cohort. Annual salary growth rates were studied from the index date (anti-TNF initiation or a randomly selected date of a non-TNF systemic prescription for the non-anti-TNF cohort). Eligible patients were followed until the end of data availability up to 5 years. Salary growth by cohort was assessed using a longitudinal regression model adjusting for baseline characteristics. Adjusted annual salary growth rates for the two cohorts were used to predict the 5-year cumulative salary difference assuming an average wage of the US general employed population ($43,212/year; 2007-2011). Results 223 and 419 actively employed AS patients were eligible to be included in the anti-TNF and the non-anti-TNF cohorts, respectively. Patients in the anti-TNF cohort were younger than those in the non-anti-TNF cohort (41.4 vs. 46.8 years, p Conclusions Compared to treating with non-anti-TNF systemic agents, anti-TNF treatments were associated with a significantly higher salary growth rate among employees with AS. Given that AS predominantly affects patients in their productive years, effective treatment can mitigate the economic burden of AS for employees as well as employers. References Boonen A. A review of work-participation, cost-of-illness and cost-effectiveness studies in ankylosing spondylitis. Nat Clin Pract Rheumatol 2006;2:546-53 Franke LC, Ament AJ, van de Laar MA, Boonen A, Severens JL. Cost-of-illness of rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 2009;27(4 supple 55):S118-23 Disclosure of Interest A. Deodhar Grant/research support from: AbbVie, Amgen, Janssen, Novartis, Pfizer, UCB, Consultant for: AbbVie, Amgen, Janssen, Novartis, Pfizer, UCB, M. Mittal Shareholder of: AbbVie, Inc., Employee of: AbbVie, Inc., A. Joshi Shareholder of: AbbVie, Inc., Employee of: AbbVie, Inc., J. Signorovitch Consultant for: AbbVie, Inc., Employee of: Analysis Group, Inc., M. Yang Consultant for: AbbVie, Inc., Employee of: Analysis Group, Inc., Y. Bao Shareholder of: AbbVie, Inc., Employee of: AbbVie, Inc." @default.
- W2414197351 created "2016-06-24" @default.
- W2414197351 creator A5015084747 @default.
- W2414197351 creator A5039428639 @default.
- W2414197351 creator A5042680411 @default.
- W2414197351 creator A5046483647 @default.
- W2414197351 creator A5068637941 @default.
- W2414197351 creator A5073499085 @default.
- W2414197351 date "2015-06-01" @default.
- W2414197351 modified "2023-10-12" @default.
- W2414197351 title "SAT0237 Assessment of Salary Growth in Patients with Ankylosing Spondylitis Treated with and Without Anti-Tumor Necrosis Factor Therapy" @default.
- W2414197351 doi "https://doi.org/10.1136/annrheumdis-2015-eular.3663" @default.
- W2414197351 hasPublicationYear "2015" @default.
- W2414197351 type Work @default.
- W2414197351 sameAs 2414197351 @default.
- W2414197351 citedByCount "0" @default.
- W2414197351 crossrefType "journal-article" @default.
- W2414197351 hasAuthorship W2414197351A5015084747 @default.
- W2414197351 hasAuthorship W2414197351A5039428639 @default.
- W2414197351 hasAuthorship W2414197351A5042680411 @default.
- W2414197351 hasAuthorship W2414197351A5046483647 @default.
- W2414197351 hasAuthorship W2414197351A5068637941 @default.
- W2414197351 hasAuthorship W2414197351A5073499085 @default.
- W2414197351 hasConcept C126322002 @default.
- W2414197351 hasConcept C141071460 @default.
- W2414197351 hasConcept C17744445 @default.
- W2414197351 hasConcept C17991360 @default.
- W2414197351 hasConcept C1862650 @default.
- W2414197351 hasConcept C198451711 @default.
- W2414197351 hasConcept C199539241 @default.
- W2414197351 hasConcept C201903717 @default.
- W2414197351 hasConcept C2776260265 @default.
- W2414197351 hasConcept C2777138892 @default.
- W2414197351 hasConcept C2777226972 @default.
- W2414197351 hasConcept C2777402515 @default.
- W2414197351 hasConcept C2777453003 @default.
- W2414197351 hasConcept C2777575956 @default.
- W2414197351 hasConcept C2780090960 @default.
- W2414197351 hasConcept C2780132546 @default.
- W2414197351 hasConcept C2780415856 @default.
- W2414197351 hasConcept C2781290027 @default.
- W2414197351 hasConcept C71924100 @default.
- W2414197351 hasConcept C72563966 @default.
- W2414197351 hasConceptScore W2414197351C126322002 @default.
- W2414197351 hasConceptScore W2414197351C141071460 @default.
- W2414197351 hasConceptScore W2414197351C17744445 @default.
- W2414197351 hasConceptScore W2414197351C17991360 @default.
- W2414197351 hasConceptScore W2414197351C1862650 @default.
- W2414197351 hasConceptScore W2414197351C198451711 @default.
- W2414197351 hasConceptScore W2414197351C199539241 @default.
- W2414197351 hasConceptScore W2414197351C201903717 @default.
- W2414197351 hasConceptScore W2414197351C2776260265 @default.
- W2414197351 hasConceptScore W2414197351C2777138892 @default.
- W2414197351 hasConceptScore W2414197351C2777226972 @default.
- W2414197351 hasConceptScore W2414197351C2777402515 @default.
- W2414197351 hasConceptScore W2414197351C2777453003 @default.
- W2414197351 hasConceptScore W2414197351C2777575956 @default.
- W2414197351 hasConceptScore W2414197351C2780090960 @default.
- W2414197351 hasConceptScore W2414197351C2780132546 @default.
- W2414197351 hasConceptScore W2414197351C2780415856 @default.
- W2414197351 hasConceptScore W2414197351C2781290027 @default.
- W2414197351 hasConceptScore W2414197351C71924100 @default.
- W2414197351 hasConceptScore W2414197351C72563966 @default.
- W2414197351 hasLocation W24141973511 @default.
- W2414197351 hasOpenAccess W2414197351 @default.
- W2414197351 hasPrimaryLocation W24141973511 @default.
- W2414197351 isParatext "false" @default.
- W2414197351 isRetracted "false" @default.
- W2414197351 magId "2414197351" @default.
- W2414197351 workType "article" @default.